ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 83 filers reported holding ENZO BIOCHEM INC in Q1 2021. The put-call ratio across all filers is 4.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,976,000 | -6.4% | 1,334,479 | -13.2% | 9.62% | +14.4% |
| Q2 2022 | $3,181,000 | -23.6% | 1,536,857 | +7.1% | 8.40% | +13.0% |
| Q1 2022 | $4,162,000 | -25.3% | 1,435,130 | -17.3% | 7.44% | -17.0% |
| Q4 2021 | $5,573,000 | +4.2% | 1,736,087 | +14.9% | 8.96% | +176.4% |
| Q3 2021 | $5,347,000 | +12.5% | 1,510,401 | +0.8% | 3.24% | -4.8% |
| Q2 2021 | $4,752,000 | +1112.2% | 1,498,902 | +864.0% | 3.40% | +963.8% |
| Q4 2020 | $392,000 | – | 155,481 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARBERT FUND ADVISORS, INC. | 5,169,337 | $17,420,000 | 25.49% |
| Roumell Asset Management, LLC | 1,236,309 | $4,166,000 | 9.86% |
| Evermore Global Advisors, LLC | 3,587,251 | $12,089,000 | 2.28% |
| CORRADO ADVISORS, LLC | 198,544 | $669,000 | 0.60% |
| Fondren Management LP | 175,863 | $593,000 | 0.56% |
| MARATHON CAPITAL MANAGEMENT | 247,130 | $832,000 | 0.34% |
| KEMPNER CAPITAL MANAGEMENT INC. | 95,476 | $322,000 | 0.21% |
| EAM Investors, LLC | 178,939 | $603,000 | 0.15% |
| Leap Investments LP | 11,811 | $40,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 75,900 | $256,000 | 0.03% |